Unexo Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 2.47 M
as on 13-12-2024
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 21.55%
(FY 2022)
- Profit -1.43%
(FY 2022)
- Ebitda 14.10%
(FY 2022)
- Net Worth 2.24%
(FY 2022)
- Total Assets 15.49%
(FY 2022)
About Unexo Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.47 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Bansal and Renu Bansal serve as directors at the Company.
- CIN/LLPIN
U74899DL1993PTC051783
- Company No.
051783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Unexo Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Bansal  | Director | 18-Oct-1993 | Current |
| Renu Bansal | Director | 01-Oct-1993 | Current |
Financial Performance of Unexo Laboratories.
Unexo Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.55% increase. The company also saw a slight decrease in profitability, with a 1.43% decrease in profit. The company's net worth moved up by a moderate rise of 2.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unexo Laboratories?
In 2020, Unexo Laboratories had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unexo Laboratories?
Unexo Laboratories has a workforce of 13 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unexo Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unexo Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
